. . . . . "\u0643\u0627\u0628\u064A\u0633\u064A\u062A\u0627\u0628\u064A\u0646\u060C \u0627\u0644\u062A\u064A \u062A\u0628\u0627\u0639 \u062A\u062D\u062A \u0627\u0633\u0645 \u0627\u0644\u0639\u0644\u0627\u0645\u0629 \u0627\u0644\u062A\u062C\u0627\u0631\u064A\u0629 \u0632\u064A\u0644\u0648\u062F\u0627 \u0648\u063A\u064A\u0631\u0647\u0627\u060C \u0647\u0648 \u0627\u0644\u0639\u0644\u0627\u062C \u0627\u0644\u0643\u064A\u0645\u064A\u0627\u0626\u064A \u0627\u0644\u0645\u0633\u062A\u062E\u062F\u0645 \u0644\u0639\u0644\u0627\u062C \u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u062B\u062F\u064A , \u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u0645\u0639\u062F\u0629 \u0648\u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u0642\u0648\u0644\u0648\u0646 \u0648\u0627\u0644\u0645\u0633\u062A\u0642\u064A\u0645. \u0644\u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u062B\u062F\u064A \u063A\u0627\u0644\u0628\u0627 \u0645\u0627 \u062A\u0633\u062A\u062E\u062F\u0645 \u062C\u0646\u0628\u0627 \u0625\u0644\u0649 \u062C\u0646\u0628 \u0645\u0639 \u062F\u0648\u0633\u064A\u062A\u0627\u0643\u0633\u064A\u0644. \u062A\u0624\u062E\u0630 \u0639\u0646 \u0637\u0631\u064A\u0642 \u0627\u0644\u0641\u0645. \u0648\u062A\u0634\u0645\u0644 \u0627\u0644\u0622\u062B\u0627\u0631 \u0627\u0644\u062C\u0627\u0646\u0628\u064A\u0629 \u0627\u0644\u0634\u0627\u0626\u0639\u0629 \u0622\u0644\u0627\u0645 \u0641\u064A \u0627\u0644\u0628\u0637\u0646\u060C \u0648\u0627\u0644\u062A\u0642\u064A\u0624\u060C \u0648\u0627\u0644\u0625\u0633\u0647\u0627\u0644\u060C \u0648\u0627\u0644\u0636\u0639\u0641\u060C \u0648\u0627\u0644\u0637\u0641\u062D \u0627\u0644\u062C\u0644\u062F\u064A. \u0648\u062A\u0634\u0645\u0644 \u0627\u0644\u0622\u062B\u0627\u0631 \u0627\u0644\u062C\u0627\u0646\u0628\u064A\u0629 \u0627\u0644\u0634\u062F\u064A\u062F\u0629 \u0627\u0644\u0623\u062E\u0631\u0649 \u0645\u0634\u0627\u0643\u0644 \u062A\u062E\u062B\u0631 \u0627\u0644\u062F\u0645\u060C \u0648\u062A\u0641\u0627\u0639\u0644\u0627\u062A \u0627\u0644\u062D\u0633\u0627\u0633\u064A\u0629\u060C \u0648\u0645\u0634\u0627\u0643\u0644 \u0641\u064A \u0627\u0644\u0642\u0644\u0628\u060C \u0648\u0627\u0646\u062E\u0641\u0627\u0636 \u0639\u062F\u062F \u062E\u0644\u0627\u064A\u0627 \u0627\u0644\u062F\u0645. \u0644\u0627 \u064A\u0646\u0635\u062D \u0628\u0623\u062E\u0630\u0647\u0627 \u0644\u0644\u0623\u0634\u062E\u0627\u0635 \u0627\u0644\u0630\u064A\u0646 \u064A\u0639\u0627\u0646\u0648\u0646 \u0645\u0646 \u0627\u0644\u0642\u0635\u0648\u0631 \u0627\u0644\u0643\u0644\u0648\u064A."@ar . "D"@en . . . . . "Rx-only"@en . . "6804DJ8Z9U" . . . "Xeloda, Xitabin, Kapetral, others"@en . . "Capecitabina"@es . . "60953"^^ . "BC06"@en . "DB01101" . . . . "1773" . . . . "D01223" . . "Capecitabin"@de . . "6804"^^ . . . . "\u5361\u57F9\u4ED6\u6EE8"@zh . . . "Kapesitabin (INN) /ke\u026Ap\u02C8sa\u026At\u0259bi\u02D0n/ (Xeloda, Roche) adalah agen kemoterapi yang diberikan lewat mulut yang digunakan dalam pengobatan berbagai jenis kanker. Kapesitabin adalah prodrug yang secara enzimatis dikonversi ke 5-fluorouracil (5-FU) di dalam tubuh. Obat ini termasuk dalam Daftar Obat Esensial Organisasi Kesehatan Dunia, daftar obat-obatan paling penting yang dibutuhkan dalam sistem kesehatan dasar."@in . "\u0643\u0627\u0628\u0633\u064A\u062A\u0627\u0628\u064A\u0646"@ar . "Capecitabine"@en . . "Capecitabine (INN, merknaam Xeloda of generisch capecitabine) is een cytostatisch geneesmiddel. Het wordt in de chemotherapie gebruikt bij de behandeling van metastatische borstkanker en darmkanker. Capecitabine is een prodrug van 5-fluoruracil (5-FU); het wordt in de tumor door enzymen ontbonden en daarbij komt het werkzame 5-fluoruracil vrij dat de DNA-synthese verstoort en de groei van de tumor afremt. Capecitabine is gebruiksvriendelijker dan 5-FU; het wordt oraal toegediend terwijl 5-FU als infuus wordt toegediend. De stof is opgenomen in de lijst van essenti\u00EBle geneesmiddelen van de WHO"@nl . . "Kapesitabin"@in . . "L01"@en . "Capecitabin (Handelsname Xeloda\u00AE, Hersteller: Roche, sowie viele Generikaanbieter) ist ein zytostatisch wirkender Arzneistoff. Capecitabin ist eine Vorstufe (Prodrug) von 5-Fluoruracil und wird im Tumor in die aktive Substanz umgewandelt. Die Substanz ist oral wirksam und wird zur Therapie von metastasiertem Dickdarmkrebs, metastasiertem oder lokal fortgeschrittenem Mammakarzinom und zur palliativen Therapie des Magenkarzinoms eingesetzt."@de . . . "250"^^ . . . . "Kapecytabina"@pl . "6799"^^ . "460016695"^^ . . "Capecitabine, sold under the brand name Xeloda among others, is a chemotherapy medication used to treat breast cancer, gastric cancer and colorectal cancer. For breast cancer it is often used together with docetaxel. It is taken by mouth. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems such as cardiomyopathy, and low blood cell counts. It is not recommended in people with kidney problems. Use during pregnancy may result in harm to the fetus. Capecitabine, inside the body, is converted to 5-fluorouracil (5-FU) through which it acts. It belongs to the class of medications known as fluoropyrimidines, which also includes 5-FU and tegafur. Capecitabine was patented in 1992 and approved for medical use in 1998. It is on the World Health Organization's List of Essential Medicines."@en . . . "Capecitabina"@it . "Capecitabin (Handelsname Xeloda\u00AE, Hersteller: Roche, sowie viele Generikaanbieter) ist ein zytostatisch wirkender Arzneistoff. Capecitabin ist eine Vorstufe (Prodrug) von 5-Fluoruracil und wird im Tumor in die aktive Substanz umgewandelt. Die Substanz ist oral wirksam und wird zur Therapie von metastasiertem Dickdarmkrebs, metastasiertem oder lokal fortgeschrittenem Mammakarzinom und zur palliativen Therapie des Magenkarzinoms eingesetzt."@de . . "Kapecytabina (\u0142ac. capecitabinum) \u2013 organiczny zwi\u0105zek chemiczny, lek cytostatyczny nale\u017C\u0105cy do grupy antymetabolit\u00F3w b\u0119d\u0105cy prekursorem 5-fluorouracylu stosowany w chemioterapii nowotwor\u00F3w z\u0142o\u015Bliwych, g\u0142\u00F3wnie w leczeniu raka jelita grubego, raka \u017Co\u0142\u0105dka i raka piersi, a tak\u017Ce raka trzustki, raka prze\u0142yku, raka szyjki macicy oraz nowotwor\u00F3w g\u0142owy i szyi."@pl . . . . . . . . . . "15"^^ . . . "Capecitabina"@pt . . "3"^^ . "GAGWJHPBXLXJQN-UORFTKCHSA-N"@en . "kidney , faecal"@en . . "1"^^ . . . "La capecitabina es un agente quimioterap\u00E9utico administrado oralmente utilizado para el tratamiento del c\u00E1ncer de mama y el c\u00E1ncer de colon."@es . "6"^^ . . "FC=1\\C\\NCOCCCCC"@en . . . . . "Xeloda, Xitabin, Kapetral, others"@en . "\u0643\u0627\u0628\u064A\u0633\u064A\u062A\u0627\u0628\u064A\u0646\u060C \u0627\u0644\u062A\u064A \u062A\u0628\u0627\u0639 \u062A\u062D\u062A \u0627\u0633\u0645 \u0627\u0644\u0639\u0644\u0627\u0645\u0629 \u0627\u0644\u062A\u062C\u0627\u0631\u064A\u0629 \u0632\u064A\u0644\u0648\u062F\u0627 \u0648\u063A\u064A\u0631\u0647\u0627\u060C \u0647\u0648 \u0627\u0644\u0639\u0644\u0627\u062C \u0627\u0644\u0643\u064A\u0645\u064A\u0627\u0626\u064A \u0627\u0644\u0645\u0633\u062A\u062E\u062F\u0645 \u0644\u0639\u0644\u0627\u062C \u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u062B\u062F\u064A , \u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u0645\u0639\u062F\u0629 \u0648\u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u0642\u0648\u0644\u0648\u0646 \u0648\u0627\u0644\u0645\u0633\u062A\u0642\u064A\u0645. \u0644\u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u062B\u062F\u064A \u063A\u0627\u0644\u0628\u0627 \u0645\u0627 \u062A\u0633\u062A\u062E\u062F\u0645 \u062C\u0646\u0628\u0627 \u0625\u0644\u0649 \u062C\u0646\u0628 \u0645\u0639 \u062F\u0648\u0633\u064A\u062A\u0627\u0643\u0633\u064A\u0644. \u062A\u0624\u062E\u0630 \u0639\u0646 \u0637\u0631\u064A\u0642 \u0627\u0644\u0641\u0645. \u0648\u062A\u0634\u0645\u0644 \u0627\u0644\u0622\u062B\u0627\u0631 \u0627\u0644\u062C\u0627\u0646\u0628\u064A\u0629 \u0627\u0644\u0634\u0627\u0626\u0639\u0629 \u0622\u0644\u0627\u0645 \u0641\u064A \u0627\u0644\u0628\u0637\u0646\u060C \u0648\u0627\u0644\u062A\u0642\u064A\u0624\u060C \u0648\u0627\u0644\u0625\u0633\u0647\u0627\u0644\u060C \u0648\u0627\u0644\u0636\u0639\u0641\u060C \u0648\u0627\u0644\u0637\u0641\u062D \u0627\u0644\u062C\u0644\u062F\u064A. \u0648\u062A\u0634\u0645\u0644 \u0627\u0644\u0622\u062B\u0627\u0631 \u0627\u0644\u062C\u0627\u0646\u0628\u064A\u0629 \u0627\u0644\u0634\u062F\u064A\u062F\u0629 \u0627\u0644\u0623\u062E\u0631\u0649 \u0645\u0634\u0627\u0643\u0644 \u062A\u062E\u062B\u0631 \u0627\u0644\u062F\u0645\u060C \u0648\u062A\u0641\u0627\u0639\u0644\u0627\u062A \u0627\u0644\u062D\u0633\u0627\u0633\u064A\u0629\u060C \u0648\u0645\u0634\u0627\u0643\u0644 \u0641\u064A \u0627\u0644\u0642\u0644\u0628\u060C \u0648\u0627\u0646\u062E\u0641\u0627\u0636 \u0639\u062F\u062F \u062E\u0644\u0627\u064A\u0627 \u0627\u0644\u062F\u0645. \u0644\u0627 \u064A\u0646\u0635\u062D \u0628\u0623\u062E\u0630\u0647\u0627 \u0644\u0644\u0623\u0634\u062E\u0627\u0635 \u0627\u0644\u0630\u064A\u0646 \u064A\u0639\u0627\u0646\u0648\u0646 \u0645\u0646 \u0627\u0644\u0642\u0635\u0648\u0631 \u0627\u0644\u0643\u0644\u0648\u064A. \u0627\u0644\u0627\u0633\u062A\u062E\u062F\u0627\u0645 \u0623\u062B\u0646\u0627\u0621 \u0627\u0644\u062D\u0645\u0644 \u0642\u062F \u064A\u0624\u062F\u064A \u0625\u0644\u0649 \u0636\u0631\u0631\u0639\u0644\u0649 \u0627\u0644\u0637\u0641\u0644. \u064A\u062A\u0645 \u062A\u062D\u0648\u064A\u0644 \u0643\u0627\u0628\u064A\u0633\u064A\u062A\u0627\u0628\u064A\u0646\u060C \u062F\u0627\u062E\u0644 \u0627\u0644\u062C\u0633\u0645\u060C \u0625\u0644\u0649 5 \u0641\u0644\u0648\u0631\u0648\u0631\u0627\u0633\u064A\u0644 (5-\u0641\u0648) \u0627\u0644\u062A\u064A \u0645\u0646 \u062E\u0644\u0627\u0644\u0647\u0627 \u064A\u0639\u0645\u0644. \u0648\u0647\u0648 \u064A\u0646\u062A\u0645\u064A \u0625\u0644\u0649 \u0641\u0626\u0629 \u0645\u0646 \u0627\u0644\u0623\u062F\u0648\u064A\u0629 \u0627\u0644\u0645\u0639\u0631\u0648\u0641\u0629 \u0628\u0627\u0633\u0645 \u0641\u0644\u0648\u0631\u0648\u0628\u064A\u0631\u064A\u0645\u064A\u062F\u064A\u0646\u0633\u060C \u0648\u0627\u0644\u0630\u064A \u064A\u062A\u0636\u0645\u0646 \u0623\u064A\u0636\u0627 5-\u0641\u0644\u0648\u0631\u0648\u064A\u0648\u0631\u0627\u0633\u064A\u0644 \u0648\u062A\u064A\u063A\u0627\u0641\u0648\u0631. \u062D\u0635\u0644 \u062F\u0648\u0627\u0621 \u0643\u0627\u0628\u064A\u0633\u064A\u062A\u0627\u0628\u064A\u0646 \u0639\u0644\u0649 \u0628\u0631\u0627\u0621\u0629 \u0627\u062E\u062A\u0631\u0627\u0639 \u0641\u064A \u0639\u0627\u0645 1992 \u0648\u062A\u0645\u062A \u0627\u0644\u0645\u0648\u0627\u0641\u0642\u0629 \u0639\u0644\u0649 \u0627\u0633\u062A\u062E\u062F\u0627\u0645\u0647 \u0637\u0628\u064A\u0627\u064B \u0641\u064A \u0639\u0627\u0645 1998. \u0648\u0647\u0648 \u0645\u062F\u0631\u062C \u0639\u0644\u0649 \u0642\u0627\u0626\u0645\u0629 \u0627\u0644\u0623\u062F\u0648\u064A\u0629 \u0627\u0644\u0623\u0633\u0627\u0633\u064A\u0629 \u0644\u0645\u0646\u0638\u0645\u0629 \u0627\u0644\u0635\u062D\u0629 \u0627\u0644\u0639\u0627\u0644\u0645\u064A\u0629\u060C \u0648\u064A\u0639\u062F \u0645\u0646 \u0627\u0644\u0623\u062F\u0648\u064A\u0629 \u0627\u0644\u0623\u0643\u062B\u0631 \u0641\u0639\u0627\u0644\u064A\u0629\u064B \u0648\u0622\u0645\u0646\u0627\u064B \u0627\u0644\u0644\u0627\u0632\u0645\u0629 \u0641\u064A \u0646\u0638\u0627\u0645 \u0627\u0644\u0631\u0639\u0627\u064A\u0629 \u0627\u0644\u0635\u062D\u064A. \u0627\u0644\u062A\u0643\u0644\u0641\u0629 \u0627\u0644\u0627\u062C\u0645\u0627\u0644\u064A\u0629 \u0641\u064A \u062F\u0648\u0644 \u0627\u0644\u0639\u0627\u0644\u0645 \u0627\u0644\u0646\u0627\u0645\u064A \u062D\u0648\u0627\u0644\u064A 122.64 \u0625\u0644\u0649 195.66 \u062F\u0648\u0644\u0627\u0631 \u0644\u0643\u0644 \u062F\u0648\u0631\u0629 \u0645\u0646 \u0627\u0644\u0623\u062F\u0648\u064A\u0629. \u0648 \u064A\u0643\u0644\u0641 \u0647\u064A\u0626\u0629 \u0627\u0644\u062E\u062F\u0645\u0627\u062A \u0627\u0644\u0635\u062D\u064A\u0629 \u0627\u0644\u0648\u0637\u0646\u064A\u0629 \u0641\u064A \u0627\u0644\u0645\u0645\u0644\u0643\u0629 \u0627\u0644\u0645\u062A\u062D\u062F\u0629 \u062D\u0648\u0627\u0644\u064A 210.67 \u00A3 \u0644\u0643\u0644 \u062F\u0648\u0631\u0629. \u0641\u064A \u0627\u0644\u0648\u0644\u0627\u064A\u0627\u062A \u0627\u0644\u0645\u062A\u062D\u062F\u0629 \u064A\u0643\u0644\u0641 \u062D\u0648\u0627\u0644\u064A 1,892.00 \u062F\u0648\u0644\u0627\u0631 \u0623\u0645\u0631\u064A\u0643\u064A \u0627\u0639\u062A\u0628\u0627\u0631\u0627 \u0645\u0646 \u0639\u0627\u0645 2016."@ar . . . . "liver, to 5'-DFCR, 5'-DFUR ; neoplastic tissue, 5'-DFUR to active fluorouracil"@en . . . "31348"^^ . . . . . . . . . "< 60%"@en . . "154361-50-9" . . "S4"@en . "154361"^^ . "Capecitabina, tamb\u00E9m conhecido pelo nome comercial Xeloda, \u00E9 um agente citot\u00F3xico, derivado do carbamato de fluoropirimidina, tumor-ativado e tumor-seletivo, que foi planejado para administra\u00E7\u00E3o oral."@pt . "Capecitabina, tamb\u00E9m conhecido pelo nome comercial Xeloda, \u00E9 um agente citot\u00F3xico, derivado do carbamato de fluoropirimidina, tumor-ativado e tumor-seletivo, que foi planejado para administra\u00E7\u00E3o oral."@pt . . "\u041A\u0430\u043F\u0435\u0446\u0438\u0442\u0430\u0431\u0438\u043D \u2014 \u043F\u0440\u043E\u0442\u0438\u0432\u043E\u043E\u043F\u0443\u0445\u043E\u043B\u0435\u0432\u044B\u0439 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442 \u0433\u0440\u0443\u043F\u043F\u044B \u0430\u043D\u0442\u0438\u043C\u0435\u0442\u0430\u0431\u043E\u043B\u0438\u0442\u043E\u0432, \u043F\u043E\u0434\u0433\u0440\u0443\u043F\u043F\u044B \u0430\u043D\u0442\u0430\u0433\u043E\u043D\u0438\u0441\u0442\u043E\u0432 \u043F\u0438\u0440\u0438\u043C\u0438\u0434\u0438\u043D\u043E\u0432."@ru . . . . . "\u041A\u0430\u043F\u0435\u0446\u0438\u0442\u0430\u0431\u0438\u043D"@ru . . . "yes"@en . . . "Pentyl [1--5-fluoro-2-oxo-1H-pyrimidin-4-yl]carbamate"@en . . . . . . . . . "a699003" . "\u041A\u0430\u043F\u0435\u0446\u0438\u0442\u0430\u0431\u0456\u043D (\u0430\u043D\u0433\u043B. Capecitabine, \u043B\u0430\u0442. Capecitabinum) \u2014 \u0441\u0438\u043D\u0442\u0435\u0442\u0438\u0447\u043D\u0438\u0439 \u043B\u0456\u043A\u0430\u0440\u0441\u044C\u043A\u0438\u0439 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442, \u044F\u043A\u0438\u0439 \u0437\u0430 \u0441\u0432\u043E\u0454\u044E \u0441\u0442\u0440\u0443\u043A\u0442\u043E\u0440\u043E\u044E \u0454 \u0430\u043D\u0430\u043B\u043E\u0433\u043E\u043C \u043F\u0456\u0440\u0438\u043C\u0456\u0434\u0438\u043D\u043E\u0432\u0438\u0445 \u043E\u0441\u043D\u043E\u0432 (\u043F\u043E\u0445\u0456\u0434\u043D\u0435 \u0444\u0442\u043E\u0440\u043F\u0456\u0440\u0438\u043C\u0456\u0434\u0438\u043D\u0443 \u043A\u0430\u0440\u0431\u0430\u043C\u0430\u0442\u0443), \u0442\u0430 \u043F\u0440\u043E\u043B\u0456\u043A\u0430\u043C\u0438 \u0456\u043D\u0448\u043E\u0433\u043E \u043B\u0456\u043A\u0430\u0440\u0441\u044C\u043A\u043E\u0433\u043E \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u0443 \u2014 5-\u0444\u0442\u043E\u0440\u0443\u0440\u0430\u0446\u0438\u043B\u0443. \u041A\u0430\u043F\u0435\u0446\u0438\u0442\u0430\u0431\u0456\u043D \u0437\u0430\u0441\u0442\u043E\u0441\u043E\u0432\u0443\u0454\u0442\u044C\u0441\u044F \u043F\u0435\u0440\u043E\u0440\u0430\u043B\u044C\u043D\u043E. \u041A\u0430\u043F\u0435\u0446\u0438\u0442\u0430\u0431\u0456\u043D \u0440\u043E\u0437\u0440\u043E\u0431\u043B\u0435\u043D\u0438\u0439 \u0443 \u043B\u0430\u0431\u043E\u0440\u0430\u0442\u043E\u0440\u0456\u0457 \u043A\u043E\u043C\u043F\u0430\u043D\u0456\u0457 (\u044F\u043A\u0430 \u0454 \u0447\u0430\u0441\u0442\u0438\u043D\u043E\u044E \u00ABHoffmann-La Roche\u00BB), \u044F\u043A\u0430 \u0440\u043E\u0437\u043F\u043E\u0447\u0430\u043B\u0430 \u0432\u0438\u043F\u0443\u0441\u043A \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u0443 \u043F\u0456\u0434 \u0442\u043E\u0440\u0433\u043E\u0432\u043E\u044E \u043C\u0430\u0440\u043A\u043E\u044E \u00AB\u041A\u0441\u0435\u043B\u043E\u0434\u0430\u00BB."@uk . . . . . . . . . . . "60953" . . . "54916"^^ . . "Kapecytabina (\u0142ac. capecitabinum) \u2013 organiczny zwi\u0105zek chemiczny, lek cytostatyczny nale\u017C\u0105cy do grupy antymetabolit\u00F3w b\u0119d\u0105cy prekursorem 5-fluorouracylu stosowany w chemioterapii nowotwor\u00F3w z\u0142o\u015Bliwych, g\u0142\u00F3wnie w leczeniu raka jelita grubego, raka \u017Co\u0142\u0105dka i raka piersi, a tak\u017Ce raka trzustki, raka prze\u0142yku, raka szyjki macicy oraz nowotwor\u00F3w g\u0142owy i szyi."@pl . "La capecitabina \u00E8 un agente chemioterapico utilizzato nel trattamento del carcinoma della mammella metastatico e nel carcinoma del colon-retto metastatico. Nel tumore del colon-retto \u00E8 utilizzata anche come terapia adiuvante, qualora il carcinoma sia classificato allo \"stadio III\" o \"stadio C di Dukes\". \u00C8 un profarmaco, enzimaticamente convertito a 5-fluorouracile, che inibisce la sintesi del DNA e rallenta la crescita del tessuto tumorale. La via di attivazione della capecitabina segue un \"pathway\" di tre passaggi enzimatici e due metaboliti intermedi, la 5'-deossi-5-fluorocitidina (5'-DFCR) e la 5'-deossi-5-fluorouridina (5'-DFUR), a formare il 5-fluorouracile (5-FU). La capecitabina \u00E8 disponibile sul mercato con il nome commerciale di Xeloda (Roche), o come prodotto generico."@it . "\u30AB\u30DA\u30B7\u30BF\u30D3\u30F3\uFF08\u82F1\u8A9E: Capecitabine\uFF09\u3068\u306F\u3001\u30D5\u30C3\u5316\u30D4\u30EA\u30DF\u30B8\u30F3\u7CFB\u4EE3\u8B1D\u62EE\u6297\u5264\u306B\u985E\u3059\u308B\u6297\u60AA\u6027\u816B\u760D\u5264\uFF08\u6297\u304C\u3093\u5264\uFF09\u3002 \u30D5\u30C3\u5316\u30D4\u30EA\u30DF\u30B8\u30F3\u7CFB\u6297\u60AA\u6027\u816B\u760D\u5264\u306E\u4EE3\u8868\u3068\u3082\u3044\u3048\u308B\u30D5\u30EB\u30AA\u30ED\u30A6\u30E9\u30B7\u30EB (5-FU) \u306F\u3001\u3053\u308C\u307E\u3067\u4E73\u764C\u3084\u6D88\u5316\u5668\u764C\u306E\u6CBB\u7642\u306B\u6700\u3082\u591A\u304F\u4F7F\u308F\u308C\u3066\u304D\u305F\u6297\u304C\u3093\u5264\u306E\u4E00\u3064\u3067\u3042\u308B\u304C\u3001\u30AB\u30DA\u30B7\u30BF\u30D3\u30F3\u306F\u3001\u9AA8\u9AC4\u7D30\u80DE\u3084\u6D88\u5316\u7BA1\u3067\u306F\u6D3B\u6027\u4F53\u306B\u306A\u308A\u306B\u304F\u304F\u816B\u760D\u7D44\u7E54\u5185\u3067\u3088\u308A\u9078\u629E\u7684\u306B5-FU\u3092\u751F\u6210\u3059\u308B\u3053\u3068\u3092\u76EE\u7684\u3068\u3057\u3066\u3001\u65E5\u672C\u30ED\u30B7\u30E5\u7814\u7A76\u6240\uFF08\u73FE\u4E2D\u5916\u88FD\u85AC\u938C\u5009\u7814\u7A76\u6240\uFF09\u3067\u5275\u88FD\u3055\u308C\u305F\u3002\u88FD\u9020\u8CA9\u58F2\u5143\u306F\u4E2D\u5916\u88FD\u85AC\u3067\u3001\u5546\u54C1\u540D\u306F\u30BC\u30ED\u30FC\u30C0 (Xeloda) \u3002"@ja . . . . "31348" . "\u041A\u0430\u043F\u0435\u0446\u0438\u0442\u0430\u0431\u0456\u043D (\u0430\u043D\u0433\u043B. Capecitabine, \u043B\u0430\u0442. Capecitabinum) \u2014 \u0441\u0438\u043D\u0442\u0435\u0442\u0438\u0447\u043D\u0438\u0439 \u043B\u0456\u043A\u0430\u0440\u0441\u044C\u043A\u0438\u0439 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442, \u044F\u043A\u0438\u0439 \u0437\u0430 \u0441\u0432\u043E\u0454\u044E \u0441\u0442\u0440\u0443\u043A\u0442\u043E\u0440\u043E\u044E \u0454 \u0430\u043D\u0430\u043B\u043E\u0433\u043E\u043C \u043F\u0456\u0440\u0438\u043C\u0456\u0434\u0438\u043D\u043E\u0432\u0438\u0445 \u043E\u0441\u043D\u043E\u0432 (\u043F\u043E\u0445\u0456\u0434\u043D\u0435 \u0444\u0442\u043E\u0440\u043F\u0456\u0440\u0438\u043C\u0456\u0434\u0438\u043D\u0443 \u043A\u0430\u0440\u0431\u0430\u043C\u0430\u0442\u0443), \u0442\u0430 \u043F\u0440\u043E\u043B\u0456\u043A\u0430\u043C\u0438 \u0456\u043D\u0448\u043E\u0433\u043E \u043B\u0456\u043A\u0430\u0440\u0441\u044C\u043A\u043E\u0433\u043E \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u0443 \u2014 5-\u0444\u0442\u043E\u0440\u0443\u0440\u0430\u0446\u0438\u043B\u0443. \u041A\u0430\u043F\u0435\u0446\u0438\u0442\u0430\u0431\u0456\u043D \u0437\u0430\u0441\u0442\u043E\u0441\u043E\u0432\u0443\u0454\u0442\u044C\u0441\u044F \u043F\u0435\u0440\u043E\u0440\u0430\u043B\u044C\u043D\u043E. \u041A\u0430\u043F\u0435\u0446\u0438\u0442\u0430\u0431\u0456\u043D \u0440\u043E\u0437\u0440\u043E\u0431\u043B\u0435\u043D\u0438\u0439 \u0443 \u043B\u0430\u0431\u043E\u0440\u0430\u0442\u043E\u0440\u0456\u0457 \u043A\u043E\u043C\u043F\u0430\u043D\u0456\u0457 (\u044F\u043A\u0430 \u0454 \u0447\u0430\u0441\u0442\u0438\u043D\u043E\u044E \u00ABHoffmann-La Roche\u00BB), \u044F\u043A\u0430 \u0440\u043E\u0437\u043F\u043E\u0447\u0430\u043B\u0430 \u0432\u0438\u043F\u0443\u0441\u043A \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u0443 \u043F\u0456\u0434 \u0442\u043E\u0440\u0433\u043E\u0432\u043E\u044E \u043C\u0430\u0440\u043A\u043E\u044E \u00AB\u041A\u0441\u0435\u043B\u043E\u0434\u0430\u00BB."@uk . . "La capecitabina \u00E8 un agente chemioterapico utilizzato nel trattamento del carcinoma della mammella metastatico e nel carcinoma del colon-retto metastatico. Nel tumore del colon-retto \u00E8 utilizzata anche come terapia adiuvante, qualora il carcinoma sia classificato allo \"stadio III\" o \"stadio C di Dukes\". \u00C8 un profarmaco, enzimaticamente convertito a 5-fluorouracile, che inibisce la sintesi del DNA e rallenta la crescita del tessuto tumorale. La via di attivazione della capecitabina segue un \"pathway\" di tre passaggi enzimatici e due metaboliti intermedi, la 5'-deossi-5-fluorocitidina (5'-DFCR) e la 5'-deossi-5-fluorouridina (5'-DFUR), a formare il 5-fluorouracile (5-FU). La capecitabina \u00E8 disponibile sul mercato con il nome commerciale di Xeloda (Roche), o come prodotto generico. La sua assunzione pu\u00F2 causare come effetto collaterale la cosiddetta sindrome mani-piedi, con desquamazione delle estremit\u00E0 e comparsa di dolorose vesciche. La sindrome mani-piedi pu\u00F2 portare alla cancellazione delle impronte digitali."@it . . . "POM"@en . "chemotherapy agent"@en . "a699003"@en . . . . . "\u041A\u0430\u043F\u0435\u0446\u0438\u0442\u0430\u0431\u0438\u043D \u2014 \u043F\u0440\u043E\u0442\u0438\u0432\u043E\u043E\u043F\u0443\u0445\u043E\u043B\u0435\u0432\u044B\u0439 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442 \u0433\u0440\u0443\u043F\u043F\u044B \u0430\u043D\u0442\u0438\u043C\u0435\u0442\u0430\u0431\u043E\u043B\u0438\u0442\u043E\u0432, \u043F\u043E\u0434\u0433\u0440\u0443\u043F\u043F\u044B \u0430\u043D\u0442\u0430\u0433\u043E\u043D\u0438\u0441\u0442\u043E\u0432 \u043F\u0438\u0440\u0438\u043C\u0438\u0434\u0438\u043D\u043E\u0432."@ru . . "D01223"@en . "Capecitabine (INN, merknaam Xeloda of generisch capecitabine) is een cytostatisch geneesmiddel. Het wordt in de chemotherapie gebruikt bij de behandeling van metastatische borstkanker en darmkanker. Capecitabine is een prodrug van 5-fluoruracil (5-FU); het wordt in de tumor door enzymen ontbonden en daarbij komt het werkzame 5-fluoruracil vrij dat de DNA-synthese verstoort en de groei van de tumor afremt. Capecitabine is gebruiksvriendelijker dan 5-FU; het wordt oraal toegediend terwijl 5-FU als infuus wordt toegediend. De stof is opgenomen in de lijst van essenti\u00EBle geneesmiddelen van de WHO"@nl . . "Cap\u00E9citabine"@fr . . "La cap\u00E9citabine est un m\u00E9dicament anticanc\u00E9reux qui appartient \u00E0 la famille des . Il interf\u00E8re avec la croissance des cellules qui se multiplient rapidement. Son originalit\u00E9 tient dans le fait qu\u2019il s\u2019agit d\u2019un m\u00E9dicament qui peut \u00EAtre pris par voie orale sur plusieurs jours en continu, \u00E0 la diff\u00E9rence des formes intraveineuses qui sont d\u2019administration intermittente. La cap\u00E9citabine est inactive, cependant une fois absorb\u00E9e elle est transform\u00E9e au niveau de la tumeur en une forme active."@fr . "D"@en . . . "Kapesitabin (INN) /ke\u026Ap\u02C8sa\u026At\u0259bi\u02D0n/ (Xeloda, Roche) adalah agen kemoterapi yang diberikan lewat mulut yang digunakan dalam pengobatan berbagai jenis kanker. Kapesitabin adalah prodrug yang secara enzimatis dikonversi ke 5-fluorouracil (5-FU) di dalam tubuh. Obat ini termasuk dalam Daftar Obat Esensial Organisasi Kesehatan Dunia, daftar obat-obatan paling penting yang dibutuhkan dalam sistem kesehatan dasar."@in . . "2073095"^^ . . . "Rx-only"@en . . "La capecitabina es un agente quimioterap\u00E9utico administrado oralmente utilizado para el tratamiento del c\u00E1ncer de mama y el c\u00E1ncer de colon."@es . "Rx-only"@en . . "\u5361\u57F9\u4ED6\u6EE8\uFF08Capecitabine\uFF09\u662F\u4E00\u79CD\u7528\u4E8E\u6CBB\u7597\u4E73\u817A\u764C\u3001\u80C3\u764C\u548C\u7ED3\u76F4\u80A0\u764C\u7684\u5316\u7597\u836F\u7269\u3002\u5BF9\u4E8E\u4E73\u817A\u764C\u60A3\u8005\uFF0C\u901A\u5E38\u6703\u5C07\u8A72\u85E5\u7269\u4E0E\u591A\u897F\u4ED6\u8CFD\uFF08Docetaxel\uFF09\u4E00\u8D77\u670D\u7528\u3002\u8A72\u85E5\u7269\u7684\u670D\u7528\u65B9\u6CD5\u662F\u53E3\u670D\u3002 \u5E38\u89C1\u7684\u526F\u4F5C\u7528\u6709\u8179\u75DB\u3001\u5455\u5410\u3001\u8179\u6CFB\u3001\u865A\u5F31\u548C\u76AE\u75B9\u3002\u5176\u4ED6\u4E25\u91CD\u7684\u526F\u4F5C\u7528\u9084\u6709\u51DD\u8840\u95EE\u9898\u3001\u8FC7\u654F\u53CD\u5E94\u3001\u5FC3\u810F\u95EE\u9898\uFF0C\u5982\u5FC3\u808C\u75C5\u3002\u80BE\u810F\u6709\u95EE\u9898\u7684\u4EBA\u4E0D\u5EFA\u8BAE\u670D\u7528\u3002\u6000\u5B55\u671F\u95F4\u670D\u7528\u53EF\u80FD\u4F1A\u5BF9\u5A74\u513F\u6709\u5BB3\u3002\u5361\u57F9\u4ED6\u6EE8\u5728\u4F53\u5185\u4F1A\u8F6C\u5316\u4E3A5-\u6C1F\u5C3F\u5627\u5576\uFF085-FU\uFF09\uFF0C\u85E5\u7269\u6B63\u662F\u901A\u8FC7\u5B83\u4F86\u53D1\u6325\u4F5C\u7528\u3002 \u5361\u57F9\u4ED6\u6EE8\u4E8E1992\u5E74\u83B7\u5F97\u4E13\u5229\uFF0C1998\u5E74\u88AB\u6279\u51C6\u7528\u4E8E\u6CBB\u7642\u3002\u5B83\u5DF2\u88AB\u5217\u5165\u4E16\u754C\u536B\u751F\u7EC4\u7EC7\u57FA\u672C\u836F\u7269\u6807\u51C6\u6E05\u5355\u3002"@zh . . "changed"@en . "Capecitabine, sold under the brand name Xeloda among others, is a chemotherapy medication used to treat breast cancer, gastric cancer and colorectal cancer. For breast cancer it is often used together with docetaxel. It is taken by mouth. Capecitabine was patented in 1992 and approved for medical use in 1998. It is on the World Health Organization's List of Essential Medicines."@en . . . "-2700.0"^^ . . . "280"^^ . . "1773"^^ . . . . . "\u30AB\u30DA\u30B7\u30BF\u30D3\u30F3"@ja . . "\u30AB\u30DA\u30B7\u30BF\u30D3\u30F3\uFF08\u82F1\u8A9E: Capecitabine\uFF09\u3068\u306F\u3001\u30D5\u30C3\u5316\u30D4\u30EA\u30DF\u30B8\u30F3\u7CFB\u4EE3\u8B1D\u62EE\u6297\u5264\u306B\u985E\u3059\u308B\u6297\u60AA\u6027\u816B\u760D\u5264\uFF08\u6297\u304C\u3093\u5264\uFF09\u3002 \u30D5\u30C3\u5316\u30D4\u30EA\u30DF\u30B8\u30F3\u7CFB\u6297\u60AA\u6027\u816B\u760D\u5264\u306E\u4EE3\u8868\u3068\u3082\u3044\u3048\u308B\u30D5\u30EB\u30AA\u30ED\u30A6\u30E9\u30B7\u30EB (5-FU) \u306F\u3001\u3053\u308C\u307E\u3067\u4E73\u764C\u3084\u6D88\u5316\u5668\u764C\u306E\u6CBB\u7642\u306B\u6700\u3082\u591A\u304F\u4F7F\u308F\u308C\u3066\u304D\u305F\u6297\u304C\u3093\u5264\u306E\u4E00\u3064\u3067\u3042\u308B\u304C\u3001\u30AB\u30DA\u30B7\u30BF\u30D3\u30F3\u306F\u3001\u9AA8\u9AC4\u7D30\u80DE\u3084\u6D88\u5316\u7BA1\u3067\u306F\u6D3B\u6027\u4F53\u306B\u306A\u308A\u306B\u304F\u304F\u816B\u760D\u7D44\u7E54\u5185\u3067\u3088\u308A\u9078\u629E\u7684\u306B5-FU\u3092\u751F\u6210\u3059\u308B\u3053\u3068\u3092\u76EE\u7684\u3068\u3057\u3066\u3001\u65E5\u672C\u30ED\u30B7\u30E5\u7814\u7A76\u6240\uFF08\u73FE\u4E2D\u5916\u88FD\u85AC\u938C\u5009\u7814\u7A76\u6240\uFF09\u3067\u5275\u88FD\u3055\u308C\u305F\u3002\u88FD\u9020\u8CA9\u58F2\u5143\u306F\u4E2D\u5916\u88FD\u85AC\u3067\u3001\u5546\u54C1\u540D\u306F\u30BC\u30ED\u30FC\u30C0 (Xeloda) \u3002"@ja . . . . . . . . "Capecitabine"@nl . . . . "\u041A\u0430\u043F\u0435\u0446\u0438\u0442\u0430\u0431\u0456\u043D"@uk . "1120658753"^^ . . . "\u5361\u57F9\u4ED6\u6EE8\uFF08Capecitabine\uFF09\u662F\u4E00\u79CD\u7528\u4E8E\u6CBB\u7597\u4E73\u817A\u764C\u3001\u80C3\u764C\u548C\u7ED3\u76F4\u80A0\u764C\u7684\u5316\u7597\u836F\u7269\u3002\u5BF9\u4E8E\u4E73\u817A\u764C\u60A3\u8005\uFF0C\u901A\u5E38\u6703\u5C07\u8A72\u85E5\u7269\u4E0E\u591A\u897F\u4ED6\u8CFD\uFF08Docetaxel\uFF09\u4E00\u8D77\u670D\u7528\u3002\u8A72\u85E5\u7269\u7684\u670D\u7528\u65B9\u6CD5\u662F\u53E3\u670D\u3002 \u5E38\u89C1\u7684\u526F\u4F5C\u7528\u6709\u8179\u75DB\u3001\u5455\u5410\u3001\u8179\u6CFB\u3001\u865A\u5F31\u548C\u76AE\u75B9\u3002\u5176\u4ED6\u4E25\u91CD\u7684\u526F\u4F5C\u7528\u9084\u6709\u51DD\u8840\u95EE\u9898\u3001\u8FC7\u654F\u53CD\u5E94\u3001\u5FC3\u810F\u95EE\u9898\uFF0C\u5982\u5FC3\u808C\u75C5\u3002\u80BE\u810F\u6709\u95EE\u9898\u7684\u4EBA\u4E0D\u5EFA\u8BAE\u670D\u7528\u3002\u6000\u5B55\u671F\u95F4\u670D\u7528\u53EF\u80FD\u4F1A\u5BF9\u5A74\u513F\u6709\u5BB3\u3002\u5361\u57F9\u4ED6\u6EE8\u5728\u4F53\u5185\u4F1A\u8F6C\u5316\u4E3A5-\u6C1F\u5C3F\u5627\u5576\uFF085-FU\uFF09\uFF0C\u85E5\u7269\u6B63\u662F\u901A\u8FC7\u5B83\u4F86\u53D1\u6325\u4F5C\u7528\u3002 \u5361\u57F9\u4ED6\u6EE8\u4E8E1992\u5E74\u83B7\u5F97\u4E13\u5229\uFF0C1998\u5E74\u88AB\u6279\u51C6\u7528\u4E8E\u6CBB\u7642\u3002\u5B83\u5DF2\u88AB\u5217\u5165\u4E16\u754C\u536B\u751F\u7EC4\u7EC7\u57FA\u672C\u836F\u7269\u6807\u51C6\u6E05\u5355\u3002"@zh . "22"^^ . . "Extensive"@en . . . "1"^^ . "DB01101"@en . "Capecitabine-from-xtal-2009-3D-balls.png"@en . . . . . . . "La cap\u00E9citabine est un m\u00E9dicament anticanc\u00E9reux qui appartient \u00E0 la famille des . Il interf\u00E8re avec la croissance des cellules qui se multiplient rapidement. Son originalit\u00E9 tient dans le fait qu\u2019il s\u2019agit d\u2019un m\u00E9dicament qui peut \u00EAtre pris par voie orale sur plusieurs jours en continu, \u00E0 la diff\u00E9rence des formes intraveineuses qui sont d\u2019administration intermittente. La cap\u00E9citabine est inactive, cependant une fois absorb\u00E9e elle est transform\u00E9e au niveau de la tumeur en une forme active."@fr . . . . "13619"^^ .